Placenta Gene Study in Early and Full-Term Pregnancy
Part of Women’s health & pregnancy clinical trials.
This study looks at gene activity in the placenta during early and full-term pregnancy. It may help researchers understand how the placenta works and how it affects both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are pregnant with one baby (not twins or more).
- Your pregnancy is between 11 and 15 weeks along.
- Your doctor has recommended a test called a chorionic villus biopsy to check for genetic issues.
- You plan to give birth at Port-Royal Maternity Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the placenta is working in pregnancies that are planned for cesarean delivery after at least 37 weeks. Researchers compare different pregnancy situations (including some common complications) and check placenta function to better understand placental health.
This study collects information from pregnant people with different risk levels to better understand and improve pregnancy care. It includes both those with known or suspected placenta issues and those with low-risk pregnancies.
This trial studies how certain drugs pass from the mother to the baby through the placenta. You may be able to help researchers understand drug safety and transfer during late pregnancy.
This study tests a new method to detect genetic information from a pregnancy as early as 7 weeks, using cells from the placenta. It may help identify certain genetic conditions earlier than standard tests.
This study collects placenta tissue (or pregnancy tissue after an abortion) to understand pregnancy problems connected to abnormal placentas. Your participation may help researchers learn what causes these problems and how to improve care.
This study looks at a possible link between certain proteins in the blood (VEGF family) and a pregnancy condition called placenta previa, using genetic information from existing studies. It is not a treatment trial, but a research study that analyzes data to understand causes.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.